Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  64 results for ""neutralizing antibodies""

Your Filters

Publisher : nature publishing group Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine.

  • Authors : Muecksch F; Department of Infectious Diseases, Heidelberg University, Medical Faculty Heidelberg, Virology, Center for Integrative Infectious Disease Research (CIID), Heidelberg, Germany.; Chica and Heinz Schaller (CHS) Research Group, Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany.

Subjects: AIDS Vaccines* ; HIV Infections*/HIV Infections*/HIV Infections*/prevention & control; Humans

  • Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2024 Feb 29; Vol. 9 (1), pp. 49. Date of Electronic Publication: 2024 Feb 29.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Humans SARS-CoV-2 variants

  • Source: Scientific reports [Sci Rep] 2023 Dec 09; Vol. 13 (1), pp. 21810. Date of Electronic Publication: 2023 Dec 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses.

  • Authors : Kuczkowska K; Nykode Therapeutics AS, Oslo Research Park, Gaustadalléen 21, 0349, Oslo, Norway. .; Bjerkan L

Subjects: Vaccines, DNA* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Cancer Vaccines*SARS-CoV-2 variants

  • Source: Scientific reports [Sci Rep] 2023 Nov 02; Vol. 13 (1), pp. 18902. Date of Electronic Publication: 2023 Nov 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Broadly neutralizing antibodies target a haemagglutinin anchor epitope.

  • Authors : Guthmiller JJ; Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL, USA. .; Han J

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; Broadly Neutralizing Antibodies*/Broadly Neutralizing Antibodies*/Broadly Neutralizing Antibodies*/immunology

  • Source: Nature [Nature] 2022 Feb; Vol. 602 (7896), pp. 314-320. Date of Electronic Publication: 2021 Dec 23.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants.

  • Authors : Andreano E; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.; Paciello I

Subjects: Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*immunology ; Broadly Neutralizing Antibodies/Broadly Neutralizing Antibodies/Broadly Neutralizing Antibodies/*immunology SARS-CoV-2 variants

  • Source: Nature [Nature] 2021 Dec; Vol. 600 (7889), pp. 530-535. Date of Electronic Publication: 2021 Oct 20.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Broad sarbecovirus neutralization by a human monoclonal antibody.

  • Authors : Tortorici MA; Department of Biochemistry, University of Washington, Seattle, WA, USA.; Institut Pasteur and CNRS UMR 3569, Unité de Virologie Structurale, Paris, France.

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*immunology ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*immunology

  • Source: Nature [Nature] 2021 Sep; Vol. 597 (7874), pp. 103-108. Date of Electronic Publication: 2021 Jul 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana.

  • Authors : Moraka NO; Botswana Harvard AIDS Institute Partnership, Bontleng, Private Bag BO320, Gaborone, Botswana.; Choga WT

Subjects: HIV Infections* ; HIV-1*/HIV-1*/HIV-1*/genetics ; HIV Seropositivity*

  • Source: Scientific reports [Sci Rep] 2023 Oct 24; Vol. 13 (1), pp. 18134. Date of Electronic Publication: 2023 Oct 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge.

  • Authors : Liu Q; State Key Laboratory of Virology, Institute for Vaccine Research, College of Life Sciences, Wuhan University, Wuhan, 430072, China.; Department of Thoracic Surgery, Renmin Hospital, Wuhan University, Wuhan, China.

Subjects: SARS-CoV-2* ; COVID-19*; Humans SARS-CoV-2 variants

  • Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2023 Sep 14; Vol. 8 (1), pp. 347. Date of Electronic Publication: 2023 Sep 14.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.

  • Authors : Starr TN; Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Czudnochowski N

Subjects: Immune Evasion*/Immune Evasion*/Immune Evasion*/genetics ; Immune Evasion*/Immune Evasion*/Immune Evasion*/immunology; Broadly Neutralizing Antibodies/Broadly Neutralizing Antibodies/Broadly Neutralizing Antibodies/*immunology

  • Source: Nature [Nature] 2021 Sep; Vol. 597 (7874), pp. 97-102. Date of Electronic Publication: 2021 Jul 14.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Repeated exposure to dengue virus elicits robust cross neutralizing antibodies against Zika virus in residents of Northeastern Thailand.

  • Authors : Hattakam S; Molecular Biotechnology Laboratory, School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima, 30000, Thailand.; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, 92037, USA.

Subjects: Antibodies, Viral* ; Broadly Neutralizing Antibodies*; Dengue Virus/Dengue Virus/Dengue Virus/*immunology

  • Source: Scientific reports [Sci Rep] 2021 May 05; Vol. 11 (1), pp. 9634. Date of Electronic Publication: 2021 May 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  64 results for ""neutralizing antibodies""